CLINICAL_TRIALS
trial_result
· 2023-09-28
Clinical Trial Update: The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB [Phase 3]
Summary
Phase 3 trial evaluating a standard regimen of anti-tuberculosis drugs for patients with multidrug-resistant tuberculosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: IUATLD, Inc | Conditions: MDR-TB | Phase 3 | Status: COMPLETED | Results posted: 2023-09-28